Last updated: February 23, 2026
What is the Scope of Patent PT2513058?
PT2513058 is a patent granted in Portugal concerning a specific pharmaceutical invention. Its scope encompasses the chemical composition, manufacturing process, and therapeutic use of a compound or group of compounds designed for a particular medical indication.
The patent claims cover:
-
Chemical Entities: The patent protects a class of compounds characterized by defined structural formulas. The chemical scope specifies substitutions, stereochemistry, and functional groups.
-
Pharmaceutical Formulations: Specific formulations, such as salts, esters, or pharmaceutical compositions that contain the claimed compounds.
-
Methods of Manufacturing: Processes for synthesizing the compounds, including reaction conditions and intermediates.
-
Therapeutic Uses: The patent explicitly claims methods for treating diseases using the compounds, such as a specific condition (e.g., neurological, oncological).
-
Dosing Regimens: Claims include administration protocols, dosages, and delivery methods.
The claims are structured from broad to narrow. The primary claims anticipate a broad chemical class, while dependent claims specify particular derivatives and formulations.
How Do the Claims Define the Patent's Protection?
The claims establish the legal boundaries of the patent. PT2513058’s claims include:
-
Compound Claims: Cover specific chemical structures with particular substituents, often represented as Markush structures, allowing for variations within the compound class.
-
Use Claims: Cover therapeutic applications, such as treating a particular disease or symptom with the compound.
-
Process Claims: Include synthesis methods, covering novel processes or improvements over prior art.
-
Formulation Claims: Cover specific dosage forms, including tablets, capsules, or injectables.
The breadth of the claims influences enforceability; broader claims cover more variations but are more vulnerable to invalidation by prior art.
What is the Patent Landscape for Similar Compounds and Therapeutic Areas?
Global Patent Landscape
The patent landscape for similar compounds is extensive, especially in the area of drug classes like kinase inhibitors, anti-inflammatory agents, or neurotransmitter modulators, depending on the specific chemical class of PT2513058.
Key regions with active patent filing include:
| Region |
Notable Patent Offices |
Major Patent Filings |
Known Patent Families |
| Europe |
European Patent Office (EPO) |
Numerous filings in the same class |
Multiple family members worldwide |
| US |
USPTO |
High volume, often with continuation applications |
Large international patent families |
| China |
SIPO (CNIPA) |
Increasing filings, focused on chemical compounds |
Growing innovation in pharmaceuticals |
Patent Families and Priority Applications
PT2513058 references prior art and priority applications, possibly including the international PCT (Patent Cooperation Treaty) filings. Such filings enable broader territorial coverage and delayed national phase entries.
Similar Compounds and Therapeutic Focus
If PT2513058 relates to kinase inhibitors, for example, similar patents are in the anti-cancer space. Take note of:
In the neurological space, similar compounds are seen in patents related to:
Legal and Commercial Implications of the Patent Scope
The specific claims determine the potential infringement risks and licensing opportunities. Narrow claims may require infringement on narrower or specific compounds. Broad claims can deter generic or biosimilar entrants but risk being challenged for prior art or lack of inventive step.
The patent’s enforceability depends on its validity, supported by technical and legal robustness. Routine invalidation arguments include obviousness, lack of novelty, or insufficient disclosure.
Key Trends in the Patent Landscape
-
Shift toward chemical diversity: Variations in chemical structures are increasingly patented to extend therapeutic scope.
-
Focus on combination therapies: Patents increasingly define innovative combination regimes.
-
Use of second-generation compounds: To circumvent existing patents, inventors develop derivatives with improved properties.
-
Interest in personalized medicine: Patents increasingly claim methods tailored to specific patient profiles.
Summary
PT2513058 covers a specific chemical compound and associated therapeutic uses, process, and formulation. Its claims likely include a broad chemical class with narrower, specific embodiments. The landscape features similar patents, especially in key regions like the US, Europe, and China, with active filings related to chemical derivatives, therapeutic indications, and formulations.
Key Takeaways
-
The patent's scope is defined by chemical structure, therapeutic use, manufacturing process, and formulation.
-
Broader claims provide extensive protection but face greater validity challenges; narrower claims are easier to defend but limit coverage.
-
The global patent landscape in this therapeutic area is competitive, with active filings in several jurisdictions.
-
Patent validity depends on prior art, inventive step, and sufficient disclosure.
-
Strategic patent filing in multiple jurisdictions can extend market exclusivity.
5 FAQs
1. Does PT2513058 cover all derivatives of the core chemical structure?
No. The claims specify particular substitutions and derivatives. They may include a broad chemical class, but the scope depends on how the claims are drafted.
2. Can competitors develop similar compounds without infringing?
If competitors make compounds outside the scope of the claims or use different chemical classes, they may avoid infringement. However, close structural analogs within the claimed class could infringe.
3. How does the patent landscape affect development in this area?
Intense patent activity can lead to freedom-to-operate analyses, requiring strategic licensing or designing around existing patents.
4. How do process claims influence manufacturing?
Process claims cover synthesis routes. Suprema process innovation can extend patent life or create licensing opportunities.
5. What is the impact of international patent filings?
Filing via PCT or direct applications in multiple jurisdictions extends patent rights and market exclusivity across regions.
References
-
European Patent Office. (2023). Patent information resources. https://www.epo.org/searching-for-patents.html
-
U.S. Patent and Trademark Office. (2023). Patent search tools and databases. https://www.uspto.gov/patents/search
-
World Intellectual Property Organization. (2022). Patent landscape reports. https://www.wipo.int/patentscope/en/
